
Path 15 Tablet
Marketer
Lupin Ltd
Salt Composition
Pioglitazone (15mg)
Overview Path 15 Tablet
Adults with type 2 diabetes mellitus can use Path 15 Tablets to manage their blood glucose. This medication helps regulate blood sugar, mitigating the risk of serious diabetic complications such as vision impairment and kidney failure. Path 15 Tablets can be administered independently or in conjunction with other medications, with or without food. For optimal effectiveness, consistent daily dosing at the same time is crucial. Dosage adjustments may occur based on your physician's assessment of its efficacy. Continuous use is vital, even with well-managed blood sugar, as discontinuation without medical supervision can elevate glucose levels, increasing the risk of kidney disease, blindness, neuropathy, and limb loss. Remember, this medication is part of a comprehensive treatment plan incorporating diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Common side effects include headache, sinusitis, myalgia, and pharyngitis; consult your doctor if these persist or are troublesome. This medication is contraindicated for individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior to starting Path 15 Tablets, inform your physician of any history of heart disease, thyroid disorders, or endocrine imbalances, as it may be unsuitable. Pregnant or lactating women must seek medical advice before initiating treatment. Regular blood glucose monitoring is essential, along with potential blood tests to track blood cell counts and liver function.
Primary Ingredients of Path 15 Tablet
No text was provided to rewrite.
Uses of Path 15 Tablet
Managing type 2 diabetes
Major Benefits of Path 15 Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Path 15 Tablets can be consumed with or without food, though consistent timing is recommended for optimal results.
Common Side effects of Path 15 Tablet:
- Headache
- Sore throat
- Sinus inflammation
- Muscle pain
How to use Path 15 Tablet:
Administer this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing. Path 15 Tablets can be consumed with or without food, although consistent timing is recommended.
How Path 15 Tablet works:
Insulinaid 15 tablets help manage diabetes by enhancing the body's response to insulin, thereby regulating blood glucose.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Path 15 Tablet is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Use of Path 15 Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.
Breast feedingCAUTION
Administering Path 15 Tablet to breastfeeding mothers requires careful consideration. Discontinue breastfeeding until the mother's treatment concludes and the medication is fully cleared from her system. Closely observe the infant's blood glucose levels throughout the duration of maternal Path 15 Tablet therapy.
DrivingSAFE
Driving ability is typically unaffected by Path 15 Tablet.
KidneySAFE IF PRESCRIBED
Path 15 Tablet poses no safety concerns for patients with renal impairment; no dosage modification is necessary.
LiverCAUTION
Individuals with liver impairment should exercise caution when taking Path 15 Tablet, potentially requiring dosage modification. Medical advice is recommended. Path 15 Tablet is contraindicated in patients exhibiting severe hepatic dysfunction.
What if you forget to take Path 15 Tablet :
Omit any missed Path 15 Tablet dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Path 15 Tablet
| Label | Value |
|---|---|
| Chemical Category | Thiazolidinedione-based compound |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Action Class | PPARγ agonist (thiazolidinedione) |
